Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Transurethral Resection of Bladder × Breast × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 12 CNS 9 Gastrointestinal 2 Dermatologic 2 Thoracic 1 Sarcoma 1 Breast 1

Conditions

Estrogen Receptor Positive Breast Cancer 1

Interventions

Trastuzumab 607 Paclitaxel 565 Cyclophosphamide 543 Docetaxel 479 Capecitabine 419 Letrozole 359 Fulvestrant 325 Carboplatin 317 Doxorubicin 284 Tamoxifen 257 Anastrozole 227 pembrolizumab 222 exemestane 211 Radiotherapy 211 Epirubicin 203 Bevacizumab 188 pertuzumab 186 palbociclib 173 Gemcitabine 172 Vinorelbine 169 Lapatinib 157 Magnetic Resonance Spectroscopy 145 130-nm albumin-bound paclitaxel 140 eribulin 132 Surveys and Questionnaires 129 Albumin-Bound Paclitaxel 129 Exercise 122 Fluorouracil 111 Drug Therapy 109 Blood Specimen Collection 105

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06629233 2025-08-29

Tn-Miner

University Ghent

Phase NA Enrolling by invitation

Estrogen Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡